Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30408140 | 0.77 | ALDH1A1 (0.33) | ALDH1A1HPGD | |
| SCHEMBL689466 | 0.75 | KMT2A (0.43) | ALDH1A1 | |
| SCHEMBL29595323 | 0.75 | ALDH1A1 (0.31) | ALDH1A1HPGD | |
| SCHEMBL29878588 | 0.74 | ALDH1A1 (0.37) | ALDH1A1HPGD | |
| SCHEMBL4723163 | 0.74 | HCAR3 (0.41) | ALDH1A1 | |
| SCHEMBL21752802 | 0.73 | KCNH3 (0.47) | ALDH1A1 | |
| SCHEMBL514930 | 0.72 | KCNH3 (0.46) | ALDH1A1 | |
| SCHEMBL4147081 | 0.71 | CYP1A2 (0.38) | ALDH1A1 | |
| SCHEMBL28859626 | 0.71 | DNM2 (0.46) | — | |
| SCHEMBL6671613 | 0.71 | DNM2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3281620-B1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND | OREAL (FR) | 2026-02-18 | — | — | EP | claimed |
| US-12102700-B2 | Fluid photoprotective composition | L'OREAL (FR) | 2024-10-01 | — | — | US | claimed |
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | claimed |
| EP-4727518-A1 | STABLE UV-SHELDING COMPOSITION | L'OREAL (FR) | 2026-04-22 | — | — | EP | disclosed |
| EP-4724153-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | Mary Kay, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-3281620-B1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND | OREAL (FR) | 2026-02-18 | — | — | EP | disclosed |
| US-20250235392-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM | L'OREAL (FR) | 2025-07-24 | — | — | US | disclosed |
| US-12303581-B2 | Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer | L'OREAL (FR) | 2025-05-20 | — | — | US | disclosed |
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2025-02-13 | — | — | US | disclosed |
| US-20250025393-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND DIPROPYLENE GLYCOL | L'OREAL (FR) | 2025-01-23 | — | — | US | disclosed |
| US-20250017835-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | L'OREAL (FR) | 2025-01-16 | — | — | US | disclosed |
| US-11458083-B2 | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | L'OREAL (FR) | 2022-10-04 | — | — | US | disclosed |
| WO-2022180010-A2 | COMPOSITION COMPRISING AN ORGANIC UV-SCREENING AGENT, A SUPERABSORBANT POLYMER, PERLITE AND A FATTY ALCOHOL | L'OREAL (FR) | 2022-09-01 | — | — | WO | disclosed |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'OREAL (FR) | 2022-07-21 | — | — | US | disclosed |
| US-11376205-B2 | Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt | L'OREAL (FR) | 2022-07-05 | — | — | US | disclosed |
| US-11344487-B2 | Photoprotective compositions comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the triplet excited level energy of the dibenzoylmethane compound | L'OREAL (FR) | 2022-05-31 | — | — | US | disclosed |
| EP-3407860-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ISOSORBIDE ETHER | OREAL (FR) | 2022-03-16 | — | — | EP | disclosed |
| EP-2470158-B1 | COMPOSITION CONTAINING AT LEAST ONE LIPOPHILIC 2-HYDROXYBENZOPHENONE FILTER AND A SILICON S-TRIAZINE SUBSTITUTED BY AT LEAST TWO ALKYLAMINOBENZOATE GROUPS | ORÉAL L (FR) | 2016-10-05 | — | — | EP | disclosed |
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | disclosed |
| EP-2193782-A1 | Cosmetic composition comprising a dibenzoylmethane derivative and a 2-pyrrolidinone-4-carboxy ester compound; method for the photostabilization of the dibenzoylmethane derivative | L'Oreal (FR) | 2010-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11458083-B2 | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | KRT18, LAGE3, TYR | ALDH1A1 1018/4885HPGD 791/4885 |
| US-11376205-B2 | Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt | KRT18, BROX, S100B | ALDH1A1 4247/4885HPGD 772/4885 |
| US-20250017835-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND RESVERATROL AND/OR A RESVERATROL DERIVATIVE | KRT18, ECH1, VIM | ALDH1A1 2200/4885HPGD 3034/4885 |
| US-20250235392-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM | KRT18, YWHAZ, BTN3A1 | ALDH1A1 756/4885HPGD 1723/4885 |
| US-11344487-B2 | Photoprotective compositions comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the triplet excited level energy of the dibenzoylmethane compound | DDT, ERCC5, ERCC1 | ALDH1A1 864/4885HPGD 1789/4885 |
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | NAPRT, NAMPT, NNMT | ALDH1A1 745/4885HPGD 8/4885 |
| US-20250025393-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND DIPROPYLENE GLYCOL | KRT18, DSC1, DSG1 | ALDH1A1 2036/4885HPGD 1866/4885 |
| US-12303581-B2 | Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer | GMNN, MGLL, DGKI | ALDH1A1 4004/4885HPGD 2826/4885 |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | ERCC5, DDT, ERCC1 | ALDH1A1 815/4885HPGD 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.